Coverage of stories discussed this week on ascopost.com: <a href= "https://ascopost.com/news/april-2020/fda-approves-luspatercept-aamt-for-second-line-treatment-of-anemia-in-mds/"> FDA Approves Luspatercept-aamt for Second-Line Treatment of Anemia in Adult Patients With Myelodysplastic Syndromes</a>

Coverage of stories discussed this week on ascopost.com: FDA Approves Luspatercept-aamt for Second-Line Treatment of Anemia in Adult Patients With Myelodysplastic Syndromes

Coverage of stories discussed this week on ascopost.com: <a href="https://ascopost.com/news/april-2020/fda-approves-luspatercept-aamt-for-second-line-treatment-of-anemia-in-mds/" rel="noopener noreferrer"> FDA Approves Luspatercept-aamt for Second-Line Treatment of Anemia in Adult Patients With Myelodysplastic Syndromes</a>

Report on the ASH COVID-19 Registry for Malignant Hematology

News and views from the world of clinical oncology and hematology.

Share Report on the ASH COVID-19 Registry for Malignant Hematology

Sign up to save your podcasts

Report on the ASH COVID-19 Registry for Malignant Hematology

Report on the ASH COVID-19 Registry for Malignant Hematology

More shows like The ASCO Post Podcast

Research To Practice | Oncology Videos

ASCO Daily News